Blog

Dr. Walter Stadler, an oncologist at the University of Chicago and a member emeritus of the Kidney Cancer Association's Medical Steering Committee, spoke to Targeted Oncology about updates and changes in how kidney cancer is treated. Read an excerpt: TARGETED ONCOLOGY: How has the setting of kidney cancer changed over the last few years? STADLER: Well, I think that if I zoom…

Bruce Hill, a kidney cancer patient, patient advocate, and member of the KCA's Patient and Caregiver Advisory Council, was featured in the spring issue of Cancer Today, the American Association for Cancer Research's quarterly magazine. Bruce described his long road to an accurate stage IV clear cell renal cell carcinoma (RCC) diagnosis and subsequent treatment with immunotherapy: The first clue ​that…

Joshuah Bledsoe Joshuah Bledsoe, a football player at the University of Missouri and an NFL draft favorite for the 2021 season, turned his attention to kidney cancer this month in order to raise awareness and funds for a disease that affects his family personally. Bledsoe’s aunt was diagnosed with stage IV renal cell carcinoma, the most common type of kidney…

Last week, the KCA hosted its very first live streaming event! The KCA's Medical Director Sallie McAdoo, MS, CGC, moderated a Facebook Live conversation on the basics of clinical trials. To help lend expertise, two members of the KCA's Patient and Caregiver Advisory Council - John Ferrell and Peggy Zuckerman - spoke about their personal experiences participating in clinical trials…

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. Facebook Live I had a great discussion about the basics of clinical trials in…

Dr. James P. Allison. © Nobel Media AB. Photo: A. Mahmoud HOUSTON – Dr. James P. “Jim” Allison, a trailblazing immunologist who won the 2018 Nobel Prize in Physiology or Medicine, will be the keynote speaker at the Kidney Cancer Association’s 2021 International Kidney Cancer Symposium (IKCS) in November in Austin, Texas. Allison, chair of Immunology and executive director of…

John Ferrell, a member of the KCA’s Patient & Caregiver Advisory Council, spoke about his work as an advocate for kidney cancer and his passion for traveling. The Kidney Cancer Association's Texas advocate group lobbied on Capitol Hill in October 2019. L-R: Bill Brown, Julie Brown, Kendall Monroe (Chief Advancement Officer, KCA), John Ferrell (Patient & Caregiver Advisory Council, KCA),…

Sarah Rosner described her father Stanley as “a girl dad, for sure.” As a kid, they would go to the movies together and play card games. When Sarah moved to Chicago as an adult, Stanley would drive in from their family home in Milwaukee, Wisconsin to visit and go to the zoo or out to lunch for dedicated father-daughter time.…

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. This month, I’m focusing on some of the data for non-clear cell renal cell…

Deborah Maskins is a long-time kidney cancer patient and advocate from Ontario, Canada. We spoke about her passion for supporting kidney cancer fellow patients.How long have you been working with the KCA and what motivated you to get involved? Having kidney cancer for most of my life has been a great motivator to get involved in organizations that are working…